Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002069316-25-000001·AP11 Ltd
Schedule 13G ownership disclosure
Sagimet Biosciences Inc
Series A common stock · CUSIP: 786700104
Event date: 2025-06-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AP11 Limited
Shares: 1,504,642.00 · Class: 4.9%
- Ascletis Pharma Inc.
Shares: 1,504,642.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002069316-25-000001
- Form type
- SCHEDULE 13G/A
- Filer
- AP11 Ltd
- CIK
- CIK 2069316
- Filed
- Jun 24, 2025
- Reporting period
- Jun 24, 2025
- Description
- Schedule 13G beneficial ownership